Combinations of drugs might increase the survival chances of COVID-19 patients: Literature review till date

SARS-COV-2 explores every possible vulnerability in human body and uses it against the host. To treat this SARS-COV-2 induced COVID-19, we should target the multiple factors virus is targeting and use the drugs in a strategical way. This approach can save the patients from severe state of illness and damage associated with the disease.

Content

Author and article information

Journal

Title: ScienceOpen Preprints

Publisher: ScienceOpen

Publication date (Electronic preprint): 13 October 2021

Affiliations

[1 ] India

Author notes

[* ]Email: sarscov2analysis33@ 123456gmail.com .

Author information

bose Karthik https://orcid.org/0000-0003-1992-461X

Article

DOI: 10.14293/S2199-1006.1.SOR-.PPY8CIF.v1

SO-VID: 73f1e5f2-3d49-4397-bf68-026469fd62d8

License:

This work has been published open access under Creative Commons Attribution License CC BY 4.0 , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Conditions, terms of use and publishing policy can be found at www.scienceopen.com .

History

Date received : 13 October 2021

Funding

No funder No grant

Data availability: Data sharing not applicable to this article as no datasets were generated or analysed during the current study.

ScienceOpen disciplines: Health & Social care,Microbiology & Virology,Infectious disease & Microbiology

Keywords: COVID-19, SARS-COV-2, Medicines